Shichun Bao Archives
Jul. 15, 2021—For patients with type 2 diabetes treated with basal or long-acting insulin, the use of continuous glucose monitors (CGMs) can result in significantly lower hemoglobin A1C (a blood test that reflects average blood glucose levels over three months), and better management of the disease according to a study recently published in the journal JAMA.
May. 25, 2017—Shichun Bao, M.D., Ph.D., associate professor of Medicine, unclips an insulin pump smaller than a deck of cards from her waistband to glance at its digital readout — but she doesn’t actually have diabetes and the pump contains only saline.